What is Travere Therapeutics, Inc.'s net investment in lease?

Travere Therapeutics, Inc. (TVTX) reported net investment in lease of $9.67M in Q1 2026.

How has Travere Therapeutics, Inc.'s net investment in lease changed year-over-year?

Travere Therapeutics, Inc.'s net investment in lease decreased by 26.7% year-over-year, from $13.2M to $9.67M.

What is the long-term trend for Travere Therapeutics, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s net investment in lease has grown at a -16.3% compound annual growth rate (CAGR), from $25.68M to $10.58M.

Travere Therapeutics, Inc. TVTX Net Investment in Lease

Net Investment in Lease at other companies

Vertex PharmaceuticalsVRTX

——

LQD

Liquidia CorporationLQDA

——

BridgeBio PharmaBBIO

——

Arrowhead ResearchARWR

——

PTC TherapeuticsPTCT

——

Scholar RockSRRK

——

Other financials

Income statement

See full

Revenue$127.2M+55.6%

Gross profit$125.2M+62.5%

Operating income-$36.9M+13.5%

Net income-$37.1M+10.0%

EPS (diluted)-$0.40+14.9%

Balance sheet

See full

Cash & equivalents$78.4M+26.6%

Total debt$15.6M-82.6%

Total equity$98.7M+201%

Total assets$555.2M+1.2%

Cash flow

See full

Operating cash flow-$40.4M+4.3%

CapEx$140.0K—

Free cash flow-$42.5M+28.1%

Valuation

See full

Market cap$5.13B+72.3%

Enterprise value$5.07B+65.5%

P/S9.6×-1.3×

Profitability

See full

Gross margin98.6%+2.6pp

Operating margin-10.6%-5.0pp

Net margin-20.3%-9.5pp

FCF margin-133.9%-34.4pp

Returns & leverage

See full

Return on equity-706%-1,302pp

Debt / equity0.2×-2.6×

Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s net investment in lease?: Travere Therapeutics, Inc. (TVTX) reported net investment in lease of $9.67M in Q1 2026.
How has Travere Therapeutics, Inc.'s net investment in lease changed year-over-year?: Travere Therapeutics, Inc.'s net investment in lease decreased by 26.7% year-over-year, from $13.2M to $9.67M.
What is the long-term trend for Travere Therapeutics, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s net investment in lease has grown at a -16.3% compound annual growth rate (CAGR), from $25.68M to $10.58M.